DR Horton (0I6K) Share Forecast & Price Target
0I6K Analyst Ratings
Hold
3Buy9Hold2Sell
Based on 14 analysts giving stock ratings to DR Horton in the past 3 months
0I6K Stock 12 Month Forecast
Average Price Target
$148.54â–²(2.16% Upside)Based on 14 Wall Street analysts offering 12 month price targets for DR Horton in the last 3 months. The average price target is $148.54 with a high forecast of $186.00 and a low forecast of $114.00. The average price target represents a 2.16% change from the last price of $145.40.
Past 12 Months12 Month ForecastJan2026Oct2026
High$186.00
Average$148.54
Low$114.00
Highest Price TargetHighest$186.00Average Price Target$148.54Lowest Price TargetLowest$114.00
Detailed List of Analyst Forecasts​
Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Anthony Pettinari | Citi | $150→$152 | hold | 4.54%Upside | Reiterated | 11/02/26 | ||
| Matthew Bouley | Barclays | $130→$125 | hold | -14.03%Downside | Reiterated | 10/30/26 | ||
| John Lovallo | UBS | $206→$186 | buy | 27.92%Upside | Reiterated | 10/30/26 | ||
| Susan Maklari | Goldman Sachs | $182→$172 | buy | 18.29%Upside | Reiterated | 10/30/26 | ||
| Stephen Kim | Evercore ISI | $166→$152 | hold | 4.54%Upside | Reiterated | 10/30/26 | ||
| Rafe Jadrosich | Bank of America Securities | $147 | hold | 1.10%Upside | Reiterated | 10/30/26 | ||
| Jade Rahmani | KBW | $152→$150 | hold | 3.16%Upside | Reiterated | 10/30/26 | ||
| Sam Reid | Wells Fargo | $140 | hold | -3.71%Downside | Assigned | 10/29/26 | ||
| Michael Dahl | RBC Capital | $119→$114 | sell | -21.60%Downside | Reiterated | 10/29/26 | ||
| Tyler Batory | Oppenheimer | ― | hold | ― | Reiterated | 10/13/26 | ||
| Michael Rehaut | Melius Research | $128 | sell | -11.97%Downside | Initiated | 10/06/26 | ||
| Adam Kramer | Morgan Stanley | $151 | hold | 3.85%Upside | Initiated | 10/01/26 | ||
| Ryan Gilbert | BTIG | $184→$174 | buy | 19.67%Upside | Reiterated | 09/22/26 | ||
| Jonathan Bettenhausen | Truist Financial | $150→$140 | hold | -3.71%Downside | Assigned | 09/16/26 | ||
| Chris Graja | Argus Research | $185 | buy | 27.24%Upside | Reiterated | 04/29/26 |
| Price Target | Follow | Article | ||||||
|---|---|---|---|---|---|---|---|---|
| Anthony Pettinari | 11/02/26 | $150→$152 | hold | 4.54%Upside | Reiterated | Citi | ||
| Matthew Bouley | 10/30/26 | $130→$125 | hold | -14.03%Downside | Reiterated | Barclays | ||
| John Lovallo | 10/30/26 | $206→$186 | buy | 27.92%Upside | Reiterated | UBS | ||
| Susan Maklari | 10/30/26 | $182→$172 | buy | 18.29%Upside | Reiterated | Goldman Sachs | ||
| Stephen Kim | 10/30/26 | $166→$152 | hold | 4.54%Upside | Reiterated | Evercore ISI | ||
| Rafe Jadrosich | 10/30/26 | $147 | hold | 1.10%Upside | Reiterated | Bank of America Securities | ||
| Jade Rahmani | 10/30/26 | $152→$150 | hold | 3.16%Upside | Reiterated | KBW | ||
| Sam Reid | 10/29/26 | $140 | hold | -3.71%Downside | Assigned | Wells Fargo | ||
| Michael Dahl | 10/29/26 | $119→$114 | sell | -21.60%Downside | Reiterated | RBC Capital | ||
| Tyler Batory | 10/13/26 | ― | hold | ― | Reiterated | Oppenheimer | ||
| Michael Rehaut | 10/06/26 | $128 | sell | -11.97%Downside | Initiated | Melius Research | ||
| Adam Kramer | 10/01/26 | $151 | hold | 3.85%Upside | Initiated | Morgan Stanley | ||
| Ryan Gilbert | 09/22/26 | $184→$174 | buy | 19.67%Upside | Reiterated | BTIG | ||
| Jonathan Bettenhausen | 09/16/26 | $150→$140 | hold | -3.71%Downside | Assigned | Truist Financial | ||
| Chris Graja | 04/29/26 | $185 | buy | 27.24%Upside | Reiterated | Argus Research |
Stocks with the Highest Top Analyst Consensus in the Consumer Cyclical Sector
Best Analysts Covering DR Horton
3 Months
Success Rate14/23 ratings generated profit
61%
Average Return
+9.65%
Copying Susan Maklari's trades and holding each position for 3 Months would result in 60.87% of your transactions generating a profit, with an average return of +9.65% per trade.
1 Year
Success Rate16/25 ratings generated profit
64%
Average Return
+21.94%
Copying John Lovallo's trades and holding each position for 1 Year would result in 64.00% of your transactions generating a profit, with an average return of +21.94% per trade.
2 Years
Success Rate18/23 ratings generated profit
78%
Average Return
+28.73%
Copying Susan Maklari's trades and holding each position for 2 Years would result in 78.26% of your transactions generating a profit, with an average return of +28.73% per trade.
0I6K Analyst Recommendation Trends
| Rating | Jun 26 | Jul 26 | Aug 26 | Sep 26 | Oct 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 4 | 4 | 5 | 4 | 4 |
| Hold | 15 | 15 | 16 | 18 | 18 |
| Sell | 1 | 1 | 1 | 3 | 3 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 20 | 20 | 22 | 25 | 25 |
In the current month, 0I6K has received 4 Buy Ratings, 18 Hold Ratings, and 3 Sell Ratings. 0I6K average Analyst price target in the past 3 months is 148.54.
0I6K Financial Forecast
High$2.24
Consensus$1.42
Low$1.17
0I6K Earnings Forecast
Next quarter’s earnings estimate for 0I6K is $1.42 with a range of $1.17 to $2.24. The previous quarter’s EPS was $2.67. Its overall industry beat the EPS estimate 50.54% of the time in the past 12 months.
High$7.56B
Consensus$6.16B
Low$5.78B
0I6K Sales Forecast
Next quarter’s sales forecast for 0I6K is $6.16B with a range of $5.78B to $7.56B. The previous quarter’s sales results were $9.37B. Its overall industry beat sales estimates 63.11% of the time in the past 12 months.
0I6K Stock Forecast FAQ
What is GB:0I6K’s average 12-month price target, according to analysts?
Based on analyst ratings, DR Horton’s 12-month average price target is $148.54.
What is GB:0I6K’s upside potential, based on the analysts’ average price target?
DR Horton has 2.16% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is DR Horton a Buy, Sell or Hold?
DR Horton has a consensus rating of Hold, which is based on 3 buy ratings, 9 hold ratings and 2 sell ratings.
What is DR Horton’s share price target?
The average share price target for DR Horton is $148.54. This is based on 14 Wall Street analysts’ 12-month price targets, issued in the past 3 months. The highest analyst share price target is $186.00, and the lowest forecast is $114.00. The average share price target represents a 2.16% increase from the current price of $145.4.
What do analysts say about DR Horton?
DR Horton’s analyst rating consensus is a Hold. This is based on the ratings of 14 Wall Street analysts.
How can I buy shares of DR Horton?
To buy shares of GB:0I6K, you can open a brokerage account. See exclusive account opening deals on our Best Online Brokers page.
